Wednesday, November 8, 2017

Glaxo Names Roche Veteran as R&D Head

GlaxoSmithKline said it appointed Hal Barron as its next chief scientific officer, snagging one of the pharmaceutical industry’s leading research luminaries to bolster its flagging drug pipeline.

from WSJ.com: US Business http://ift.tt/2zsMjRE
via IFTTT

No comments:

Post a Comment